Did you know there’s even more we can do to promote your episode? Find out more…
Episode 226
The cancer Doc, driven by impact
Tim Showalter
/ ArteraAI
Explore how Dr. Tim Showalter, Radiation Oncologist and CMO at ArteraAI, is transforming prostate cancer care with AI-powered diagnostics.
Episode 225
The GM focused on inhaled & nasal drugs
Gemma Budd
/ Nanopharm
Gemma Budd, GM at Nanopharm, shares insights on inhalation drug delivery, CRO leadership, and driving pharmaceutical innovation in nasal and pulmonary therapies.
Episode 224
The impact of a CEO who loves to work
Jeanne Taylor Hecht
/ Lexitas
Meet Jeanne Lexitas CEO & Chairwoman, biotech board leader, ophthalmology CRO specialist, and global pharma advisor passionate about patient-focused innovation.
Episode 223
From brink of bankruptcy to boom
Garren Hillow
/ Executive coach & author
Discover how biotech entrepreneur Garren Hilow built and sold Abveris for $190M without VC funding. A must-listen for life science founders seeking scalable, founder-friendly growth.
Episode 222
The CEO addicted to challenge
Angelo Gatto
/ Chanelle Pharma
Discover Angelo Gatto’s journey from Big Pharma to CEO of Chanelle Pharma, driving growth in CDMO and animal health innovation.
Episode 221
The COO leveraging the ‘power of we’
Christiane Bardroff
/ Rentschler Biopharma SE
Hear from Christiane Bardroff, COO of Rentschler Biopharma, as she shares insights on biologics, leadership, and scaling global operations.
Episode 220
The pharma CEO focused on US commercial growth
Adriana Herrera
/ Pierre Fabre Pharmaceuticals (USA).
Explore Adriana Herrera’s journey from Kite Pharma to CEO at Pierre Fabre USA, leading in cell therapy, oncology, and pharma innovation.
Episode 219
The Spanish solid state specialist
Victor Diaz
/ Solitek
Discover Victor Diaz’s journey from medicinal chemist to co-founder of Solitek, and his insights on solid-state chemistry, AI in drug development, and the future of CROs/CDMOs.
Episode 218
The bullish CDMO CEO making bold moves
Jeremie Trouchu
/ Ardena
Hear Jeremie Trochu’s journey from GE to Catalent and now Ardena, as he shares insights on CDMO growth and navigating the pharma landscape.
Episode 217
Geordie lad done good in pharma
Rob Wood
/
Discover Rob Wood’s journey from founding STEM to leading pharma investments and launching an academy for future entrepreneurs.
